ArticleBioengineering (Basel, Switzerland)2026
Parameter-Reduced YOLOv8n with GhostConv and C3Ghost for Automated Blood Cell Detection.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurate detection of blood cells in microscopic images plays a crucial role in automated hematological analysis and clinical diagnosis. Herein, we proposed an improved YOLOv8n-based model for efficient and precise detection of red blood cells (RBCs), white blood cells (WBCs), and platelets in the BCCD dataset. The baseline YOLOv8n framework was enhanced by integrating GhostConv and C3Ghost modules to reduce model complexity while maintaining high detection performance. A series of ablation experiments were conducted to evaluate the individual and combined effects of these modules on model accuracy and computational efficiency. Experimental results demonstrated that the baseline model achieved an mAP@0.5 of 0.9043 with 3.01 M parameters. After incorporating GhostConv, the model maintained comparable accuracy (mAP@0.5 = 0.9040) with a reduction in parameters to 2.73 M. The C3Ghost integration further decreased parameters to 1.99 M with an mAP@0.5 of 0.8973. The combined model achieved an optimal balance between accuracy (mAP@0.5 = 0.9001) and compactness (1.71 M parameters). Results indicate that the improved YOLOv8n can effectively enhance detection efficiency without sacrificing precision. The proposed lightweight detection framework provides a promising solution for real-time blood cell analysis. Its high accuracy, reduced computational load, and strong generalization ability make it suitable for integration into automated laboratory systems, facilitating rapid and intelligent medical diagnostics in hematology and related biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.